Global Phenobarbital Market: Introduction

Phenobarbital is a long-acting barbiturate, an anti-epileptic medication (AED) that sedates the nervous system. It is generally prescribed by health care professionals to avoid seizures or to ease anxiety. Phenobarbital is often recommended to treat disorders such as epilepsy and seizure because the drug stabilizes electrical activity in the brain. Phenobarbital is a drug class known as anticonvulsants /hypnotics barbiturate. This medication is also used for a brief period of time (generally not more than 2 weeks) to assist individuals to calm down or help them sleep during anxiety periods. It operates to trigger calming by influencing certain components of the brain. Phenobarbital is taken by mouth in the form of tablet or an elixir (liquid). Usually, its dosage is one to three times a day.

To Know the Segments Analyzed in the Phenobarbital Market Report, Ask for a Brochure here

Global Phenobarbital Market: Competitive Landscape

Novartis AG

Founded in 1996, Novartis AG is among the top global pharmaceutical companies operating across all the regions in almost all the specialties. Novartis operates in patented pharmaceutical products, generic pharmaceuticals & biosimilars, and surgical and vision care segments. It offers many OTC as well as generic drugs for acute attack treatment of migraine. The company is investing into specialty prophylactic treatment drugs through its recent acquisitions and strategic collaborations.

Sanofi S.A.

Incorporated in 2004, Sanofi, formerly Sanofi-Aventis, is a health care corporation involved in the research, development, production, and marketing of therapeutic solutions. The company operates through three major business segments: Vaccines, Pharmaceuticals, and Animal Health Care. 

Other key players operating in the global Phenobarbital market include AstraZeneca Plc., Allergan Plc., GlaxoSmithKline Plc., Eli Lilly & Company, Merck & Co., Inc., Arrow Pharmaceuticals, Janssen Pharmaceutical Company (Johnson & Johnson),  and Dainippon Sumitomo Pharma. 

To Know More about TMRs Unique Offerings for Phenobarbital Market, Request a Custom Report here

Global Phenobarbital Market: Dynamics

High Prevalence of Epilepsy to Drive Market

Epilepsy is a chronic neurological disorder with approximately 50 million patient population. The growing incidence of illnesses is expected to increase the demand for epilepsy treatment and hence, the phenobarbital market. 

Rise in Geriatric Population to Boost Market

Epilepsy is common among both kids and adults. However, elderly population is more likely to be impacted by this disorder. It is predicted that increase in geriatric population is likely to increase demand for epilepsy treatment. This, in turn, is expected to boost the phenobarbital market in the next few years.   

Global Phenobarbital Market: Segmentation

The global phenobarbital market can be segmented based on:

  • Indications
  • Route of Administration
  • Distribution Channel

Global Phenobarbital Market, by Indications

In terms of indications, the global phenobarbital market can be divided into:

  • Epileptic Seizures
  • Anxiety
  • Others

Global Phenobarbital Market, by Route of Administration

Based on route of administration, the global phenobarbital market can be classified into:

  • Oral
  • Injectable
  • Others

Global Phenobarbital Market, by Distribution Channel

In terms of distribution channel, the global phenobarbital market can be segregated into:

  • Hospitals Pharmacies
  • Retail Pharmacies
  • Others (online pharmacies, drug stores)

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

The study is a source of reliable data on:

  • Market segments and sub-segments
  • Market trends and dynamics
  • Supply and demand
  • Market size
  • Current trends/opportunities/challenges
  • Competitive landscape
  • Technological breakthroughs
  • Value chain and stakeholder analysis

The regional analysis covers:

  • North America (U.S. and Canada)
  • Latin America (Mexico, Brazil, Peru, Chile, and others)
  • Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
  • Eastern Europe (Poland and Russia)
  • Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
  • Middle East and Africa (GCC, Southern Africa, and North Africa)

The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.

A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.

Highlights of the report:

  • A complete backdrop analysis, which includes an assessment of the parent market
  • Important changes in market dynamics
  • Market segmentation up to the second or third level
  • Historical, current, and projected size of the market from the standpoint of both value and volume
  • Reporting and evaluation of recent industry developments
  • Market shares and strategies of key players
  • Emerging niche segments and regional markets
  • An objective assessment of the trajectory of the market
  • Recommendations to companies for strengthening their foothold in the market   

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.